Skip to main content
|

Renown Expands Cancer Care Leadership with New Section Chief of Oncology

By:
  • Renown Public Relations
October 2, 2025
Renown Health logo

Dr. Harry Menon Named Oncology Section Chief

Renown Health is delighted to announce the promotion of Dr. Harry Menon to Section Chief of Oncology for the William N. Pennington Cancer Institute at Renown Health, effective immediately. Dr. Menon has been a dedicated Hematology/Oncology Physician since August 2021 and has also been serving as an Assistant Professor of Clinical Internal Medicine at the University of Nevada, Reno School of Medicine. In this leadership role, Dr. Menon will oversee clinical programs, advance cancer research and innovation, and guide a multi-disciplinary team dedicated to providing exceptional care for patients and families across northern Nevada.

Dr. Menon brings a wealth of experience and expertise to his new role. He completed his fellowship in Hematology & Oncology at Pennsylvania State University Milton S. Hershey Medical Center, where he also served as Chief Fellow. Prior to that he completed a residency in Internal Medicine at Inspira Health Network in New Jersey, where he also served as Chief Resident. His academic study includes a D.O. from Lake Erie College of Osteopathic Medicine, an M.P.H. from Boston University with a concentration in Epidemiology, Health Policy & Management, and a B.S. from Pennsylvania State University in Biochemistry and Molecular Biology.

Dr. Menon has made significant contributions to the field through his research and publications. He has authored multiple peer-reviewed articles on topics including cancer therapy, COVID-19 impact on patients with cancer, and biomarkers in cancer. His research interests include ctDNA assays, electronic patient-reported outcomes development and public health projects addressing cancer in unhoused populations. His work has been published in prestigious journals such as JAMA Network Open and Annals of Oncology. He has also presented at numerous conferences, including the ASCO Annual Meeting and the American Society of Hematology Annual Meeting. Dr. Menon is board-certified in Hematology, Medical Oncology and Internal Medicine.

Expanding Cancer Care and Research in Nevada

As Section Chief, Dr. Menon will collaborate with colleagues across Renown Heath and the University of Nevada, Reno School of Medicine to expand access to advanced cancer therapies, clinical trials, and supportive care service, ensuring that patients receive the highest-quality care close to home.

Dr. Menon’s office is located within Renown Hematology/Oncology at 75 Pringle Way, Ste 801 in Reno, NV. People interested in scheduling an appointment with Dr. Menon can call Renown’s oncology scheduling line at 775-982-4000.


About Renown Health

Renown Health is the region’s largest, locally governed, not-for-profit integrated academic health care network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 8,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Related News

Renown Health logo

Renown Health Expands Access to Advanced Deep Brain Stimulation Care

Renown Health is expanding access to advanced neurological care with the availability of Deep Brain Stimulation (DBS) surgery at the Renown Institute for Neurosciences, bringing one of the most sophisticated treatments for movement disorders, such as Parkinson's disease, closer to home for patients across northern Nevada. “The availability of Deep Brain Stimulation at Renown represents a significant step forward in the level of neurological care we can provide locally,” said Chris Nicholas, MHA, FACHE, CEO, Renown Regional Medical Center and COO, Renown Health. “DBS is a highly specialized therapy that requires advanced technology, surgical expertise and a coordinated care team. By bringing this treatment closer to home, we’re improving access to essential and advanced care options while helping patients achieve better outcomes and quality of life.” DBS is used to help manage symptoms of Parkinson’s disease, essential tremor and dystonia; a neurological movement disorder causing involuntary, sustained or repetitive muscle contractions, leading to twisting movements, abnormal postures and sometimes pain, affecting one muscle or the whole body, when medications alone are no longer effective. DBS uses targeted electrical impulses delivered to specific areas of the brain to help regulate abnormal neurological signals. For many patients with movement disorders, DBS can significantly improve symptoms, restore independence and enhance quality of life. This milestone was made possible in part through the generosity of eight local foundations and individual donors, coordinated by the Renown Health Foundation. Contributions ranged from $5,000 to $333,000, reflecting a shared commitment to advancing specialized care in the region. “Philanthropic support played a critical role in making Deep Brain Stimulation available at Renown. Investments from local foundations and individual donors helped fund the advanced technology and infrastructure required to launch this highly specialized program,” said Gregory Walaitis, MEd, Chief Development Officer at Renown Health. “Their generosity is directly expanding access to leading-edge neurological care, allowing patients in our region to receive complex, life-changing treatment close to home and reinforcing Renown’s commitment to innovation and excellence in patient care.”
Read More Renown Health Expands Access to Advanced Deep Brain Stimulation Care
View All Press Releases
ER Wait Times

How are wait times calculated?

Our estimated ER wait times reflect the average time from check-in to being seen by a medical professional during triage, where patients are prioritized based on the severity of their condition.

Health & Wellness eNews
Sign Up